---

$1.76

+0.0050 ( +0.29% ) 0.1K

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-10-29	Buy	1915700.00	ARCH Venture Partners X, LLC
2025-10-29	Buy	1915700.00	ARCH Venture Partners XII, LLC
2025-10-29	Buy	1915700.00	ARCH Venture Partners XII, LLC
2025-10-29	Buy	1915700.00	Burow Kristina
2024-06-28	Sale	-238965.00	Pinto Joshua
2024-06-14	Sale	-20100.00	Halawa Alaa
2024-06-14	Sale	-20100.00	Piacquad David
2024-06-14	Sale	-20100.00	Fust Matthew K
2024-06-14	Sale	-20100.00	Ho Maykin
2024-06-14	Sale	-20100.00	Burow Kristina